News
Third quarter results 2003
22.10.2003 - Nutri Pharma ASA (OSE: NUT) today announced that its loss for the first 9 months of 2003 was NOK 8.5 million compared to a loss of NOK 47.4 million the same period last year....
Read more about Third quarter results 2003First half results 2003
18.06.2003 - Nutri Pharma ASA (OSE: NUT) today announced that its profit for the first half of 2003 was NOK 1.1 million compared to a loss of NOK 35.9 million the same period last year...
Read more about First half results 2003The Board of Directors of Nutri Pharma ASA proposes distribution to shareholders of NOK 2.75 per share
18.06.2003 - The Board of Directors of Nutri Pharma ASA has unanimously decided to propose to the shareholders at an extraordinary shareholders’ meeting of the Company that NOK 2.75 per issued share ...
Read more about The Board of Directors of Nutri Pharma ASA proposes distribution to shareholders of NOK 2.75 per shareJoint venture with Nycomed dissolved and royalty agreement entered into
25.07.2003 - Nutri Pharma ASA (OSE: NUT) today announced that Nutri Pharma and Nycomed Pharma AS have agreed to dissolve the Nutrition Partners joint venture....
Read more about Joint venture with Nycomed dissolved and royalty agreement entered intoNutri Pharma’s Soy Composition Granted Two Additional Patents
June 2003 - Patent: Composition and Its Use as a Food Supplement or for Lowering Lipids in Serum...
Read more about Nutri Pharma’s Soy Composition Granted Two Additional PatentsNews Article: Nutri Pharma Presents Latest Research Findings at the European Congress on Obesity
May 2003 - Nutri Pharma`s Weight Management Product Provides More Weight Loss Than Slim Fast....
Read more about News Article: Nutri Pharma Presents Latest Research Findings at the European Congress on ObesityNutri Pharma’s New Isolated Soy Protein Significantly More Effective to Lower Total and LDL Cholesterol than the Best Commercially Available Soy Protein
12.05.2003 - Nutri Pharma announced today the results of a clinical trial demonstrating that its new isolated soy protein (ISP) is significantly better at lowering serum cholesterol values...
Read more about Nutri Pharma’s New Isolated Soy Protein Significantly More Effective to Lower Total and LDL Cholesterol than the Best Commercially Available Soy ProteinFirst quarter results 2003
25.04.2003 - Nutri Pharma ASA (OSE: NUT) today announced that its loss for Q1 2003 was NOK 2.8 million compared to a loss of NOK 16.3 million the same period last year.....
Read more about First quarter results 2003Abacor® Proven To Have Significant Additional Cholesterol Lowering Effects In Statin Treated Patients
09.04.2003 - Amersham, Bucks, April 2003 – Nutri Pharma’s patented soy composition Abacor® is reported today, at the New Functional Ingredients and Foods (NFIF) conference in Copenhagen, to have....
Read more about Abacor® Proven To Have Significant Additional Cholesterol Lowering Effects In Statin Treated PatientsNews Article: Soy specialist doubles sales through weight-loss focus
March 2003 - The consolidation of its Scandinavian joint venture with Nycomed lifted sales by 223% in 2002 for weight-loss science specialist Nutri Pharma.....
Read more about News Article: Soy specialist doubles sales through weight-loss focusAnnual General Meeting
12.03.2003 - The Annual General Meeting (AGM) of Nutri Pharma ASA today approved the board of directors` proposal for annual accounts and directors` report including the board of directors` proposal for coverage of the loss for 2002....
Read more about Annual General MeetingOrganisational Change
12.03.2003 - Eirik Uboe, CFO/COO of Nutri Pharma has today been appointed Managing Director of Nutri Pharma ASA.....
Read more about Organisational ChangeNews Article: Regulatory & scientific studies
05.03.2003 - A comparative study, emanating from a recent patent application, has documented that Nutri Pharma's soy composition Abacor is significantly more effective at lowering cholesterol ....
Read more about News Article: Regulatory & scientific studiesNews Article: Nutri Pharma's new soy composition found much more effective at reducing cholesterol than soy protein alone
03.03.2003 - Amersham, Bucks, February 2003 – A comparative study, emanating from a recent patent application, documents that Nutri Pharma’s soy composition Abacor®, is significantly more effective at lowering cholesterol compared to the best commercially available soy protein. ...
Read more about News Article: Nutri Pharma's new soy composition found much more effective at reducing cholesterol than soy protein aloneColombia University Trial: Scan Diet Significantly More Effective Than Trying To Lose Weight On One’s Own With The ADA Recommended Diet
February 2003 - In the upcoming issue of the European Journal of Clinical Nutrition (March 2003) a landmark clinical study has found Scan Diet to be more effective at helping people achieve weight loss than....
Read more about Colombia University Trial: Scan Diet Significantly More Effective Than Trying To Lose Weight On One’s Own With The ADA Recommended DietNews article: Abacor beats the best
28.02.2003 - The soy composition Abacor is significantly more effective at lowering cholesterol than other commercially available soy protein, according to the ingredient’s maker Norwegian firm NutriPharma....
Read more about News article: Abacor beats the bestFourth quarter and preliminary results 2002
05.02.2003 - Nutri Pharma ASA (OSE: NUT) today announced that as a result of its JV with Nycomed Pharma revenues grew by 223% from NOK 15.9 million in 2001 to NOK 51.3 million in 2002 while the operating result has improved from NOK –160.5 million to NOK –80.9 million....
Read more about Fourth quarter and preliminary results 2002News article . Proprietary Soy Products From Europe
January/February 2003 - Historically soy foods have been used in Asia for thousands of years and are regarded as healthy and safe. In Western Europe soy preparations are used mostly for their health benefits for people with lactose allergies or in specialized formulations.....
Read more about News article . Proprietary Soy Products From EuropeNews article: Patent Assigned to Nutri Pharma ASA
21.01.2003 - Patent Assigned to Nutri Pharma ASA
– A Soy composition Suitable for the Treatment and Prevention of Pulmonary Diseases....